A number of studies have indicated that 40Á70% of the variation in body mass index (BMI) and body fat mass is genetically determined (COMUZZIE and ALLISON 1998) . Although several single gene mutations cause obesity in animal models, the situation in the common form of human obesity is much more complex. Human obesity is determined by the interaction of multiple genes, as well as environmental factors, behaviors, and dietary patterns (RICE et al. 1996) .
As one of the risk factors for obesity, low energy expenditure can increase obesity and related metabolic disorders when accumulated over decades (RAVUSSIN et al. 1998) . Uncoupling proteins (UCPs), which are located in the mitochondrial inner membrane, are well-known to regulate energy expenditure and fat oxidation (GURA 1998) . UCPs dissipate the proton electrochemical gradient, so that the energy is converted to heat without the synthesis of ATP (GARLID et al. 1996) . Among the UCP family members, the human UCP-1 gene was cloned and shown to be located on chromosome 4 by Cassard et al. in 1990 (CASSARD et al. 1990 OPPERT et al. 1994) . In 1997, Fleury et al. found that the human UCP-2 gene is located on chromosome 11, notably, on a region that has been linked to obesity and hyperinsulinemia (FLEURY et al. 1997) . Unlike UCP-1, which is exclusively expressed in brown adipose tissue (BAT), UCP-2 is expressed in a variety of different tissues, including white adipose tissue, skeletal muscle, heart, liver and kidney tissue (FLEURY et al. 1997) . SURWIT et al. reported that UCP-2 mRNA expression was more than two-fold higher in the white adipose tissue of obesity-resistant mice compared to that of obesityprone mice (SURWIT et al. 1998) . It was also reported that the expression of UCP-2 is increased by high fat diet and leptin treatment (RIPPE et al. 2000; SANIGORSKI et al. 2000; ZHANG et al. 2004) .
In genetic polymorphism studies of UCP-2, five polymorphisms in the promoter region and a 45 bp insertion/deletion were found in the 3?-untranslated region (ESTERBAUER et al. 2001 ). In the coding region, a polymorphism of alanine to valine at the 55th codon, Ala55Val, was also found in exon 4 (UHAMMER et al.
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However, few studies were conducted to elucidate the effects of the Ala55Val polymorphism on computed tomography (CT)-measured body fat characteristics and calorie restriction-induced changes in East Asian populations. In this study, we analyzed the association of this polymorphism with body fat area and calorie restriction-induced changes of body components in Korean female subjects.
MATERIAL AND METHODS

Subjects
In this study, 386 Korean female subjects were recruited from Kirin Oriental Medical Hospital (Seoul, Republic of Korea). The general characteristics of the subjects were: age, 27.0890.40 (mean9SE); weight, 68.6290.65 kg; BMI, 26.4490.22 kg m (2 ; waist-to-hip ratio (WHR), 0.88990.004; systolic blood pressure, 115.6190.70 mm Hg; diastolic blood pressure, 72.0590.56 mm Hg. Genomic DNA was obtained with informed consent, and the protocol of this study was approved by the Institutional Review Board of the Korea Institute of Oriental Medicine. Body compositions were measured by bio-impedance analysis using a commercial device (Inbody 2.0, Biospace Co., Republic of Korea). The areas of abdominal subcutaneous and visceral fat of all subjects were measured from CT cross-sectional images of the abdominal region, as described previously (MATSUZAWA 1995) . The subcutaneous fat areas at the thigh were also measured using CT (Hispeed CT/e, GE, USA). Among all 386 subjects, 236 subjects finished the 1-month weight loss program, which consisted of a 700 kcal day (1 calorie restriction, with 130 g carbohydrate and 70 g protein per day. Changes in body weight, BMI, and body compositions before and after the program were assesseds.
Genotyping assay
Genomic DNA from each subject was extracted from blood using a Qiagen DNA blood kit according to the instructions of the manufacturer. The genotyping of the Ala55Val polymorphism was based on the analysis of primer extension products generated from previously amplified genomic DNA using a chip-based matrix-assisted laser desorption/ionization time of flight (MALDI-TOF) mass spectrometry platform (SEQUENOM, Inc., CA). The general procedures were performed according to standard protocol of the manufacturer. Primers for PCR and primer extension analysis were designed using the Primer3 program (http://primer3.sourceforge.net). Each allele-specific primer extension product was analyzed in the fully automated mode with the MALDI-TOF MassAR-RAY system (Bruker-SEQUENOM, CA).
The primer sequences used for genotyping are listed below:
forward primer: ACGTTGGATGGCATCGAGA-TGACTGGAGGT reverse primer: ACGTTGGATGGTCAGAATG-GTGCCCATCAC PCR product size: 149 bp extension primer: GGGCCAGTGCGCGCTA-CAG
Serum biochemical profile analysis
Blood samples were obtained from each subject after fasting overnight for more than 12 h, and were centrifuged at 2000 rpm for 10 min. Serum levels of total cholesterol, HDL cholesterol, LDL cholesterol, triglyceride, glucose, LDH, albumin, GOT, and GPT were measured by auto-biochemical analyzer (SP-4410, ARKRAY, Japan).
Statistical analysis
All values were presented as mean9SE. Age-adjusted univariate analysis of variance was performed by a general linear model procedure to examine the independent effect of the Ala55Val polymorphism on dependent variables. To compare the outcomes of the calorie-restriction program, general linear model analyses were conducted after the adjustment of the initial value of body weight, BMI, or body compositions, as well as age. Statistical significance was established at the level of p B0.05. All analyses were performed using SPSS ver. 10.0 (SPSS Inc., IL).
RESULTS
The frequencies of the genotypes in the UCP-2 Ala55Val polymorphism were measured among 386 Korean female subjects. It was shown that the AlaAla type was present in 30.3% (n 0117) of the population, while the AlaVal type was present in 47.2% (n0182), and ValVal type in 22.5% (n 087) of the population. This was in agreement with Hardy-Weinberg equilibrium (p 00.314). The frequency of the major Ala allele was 0.54, and that of the minor Val allele was 0.46. The allelic frequencies were similar to the findings of previous studies conducted in Caucasian populations (ASTRUP et al. 1999; KLANNEMARK et al. 1998; ROSMOND et al. 2002) . Table 1 shows the comparison of the physical characteristics and body compositions of the subjects by Ala55Val polymorphism. The mean body weight and BMI were lower in the ValVal type compared with the AlaAla or AlaVal type, although these differences were not statistically significant. When body composition was measured by bio-impedance analysis, body fat mass was significantly lower in subjects with the ValVal type compared with those with the AlaAla or AlaVal type (p00.044), and the body fat percentage also tended to be decreased in the ValVal type (p00.053). In contrast, lean body mass, protein mass, mineral mass, and water content showed no differences according to the Ala55Val polymorphism.
For the accurate evaluation of the effects of the Ala55Val polymorphism on body fat, the subjects were tested using CT to measure the cross-sectional fat tissue areas at the abdominal and distal portions of the body. An example of CT-measured body fat area is shown in Fig. 1 . The abdominal subcutaneous fat area and total abdominal fat area were about 11% smaller in subjects with the ValVal type compared to those with the AlaAla or AlaVal type (p00.044 and p 0 0.043, respectively) (Table 2) . However, the visceral fat area, visceral fat to subcutaneous fat ratio, and thigh subcutaneous fat area did not differ significantly according to the Ala55Val polymorphism.
Among all subjects, 236 females finished the 1-month calorie restriction program. The changes in weight and body compositions during the program were compared according to Ala55Val polymorphism (Table 3 ). The reduction of body weight tended to be smaller in the ValVal type (p 00.073) than in the other types, and this tendency remained after adjustment for initial body weight (p 00.082). Among the changes in body composition, only the fat change was shown to differ significantly according to Ala55Val genotype (p00.016). The reduction of body fat was about 21% smaller in the ValVal type compared with the other types. After adjustment for initial fat mass, subjects with the ValVal type still tended to show a lower degree of body fat reduction (p00.085). The changes in other components of the body, such as protein, mineral, and water, showed no significant differences according to the Ala55Val polymorphism. The comparison of serum biochemical characteristics of the subjects by Ala55Val polymorphism showed no significant differences (Table 4 ).
DISCUSSION
Many studies have recently been performed to determine the genetic risk factors of obesity and related metabolic disorders (COMUZZIE and ALLISON 1998). UCP-2, which is expressed in various tissue types, is among the candidate factors. Until now, seven genetic polymorphisms were reported in the UCP-2 gene. In the promoter region, T-2723A, G-1957A, G-866A, G-371C and 13 bp deletion/insertion polymorphisms have been found (ESTERBAUER et al. 2001) . Ala55Val in exon 4 and the 45 bp deletion/insertion in the 3?-untranslatied region have also been reported (UHAMMER et al. 1997) . Several previous studies were conducted to determine the relationships between UCP-2 polymorphisms and weight gain, BMI, and energy expenditure (UHAMMER et al. 1997; KLANNEMARK et al. 1998; ASTRUP et al. 1999; BUEMANN et al. 2001; ESTERBAUER et al. 2001; ROSMOND et al. 2002; MAESTRINI et al. 2003) .
In this paper, we elucidated the association between Ala55Val polymorphism and body fat in 386 Korean female subjects. The frequency of the Val allele was 0.46, a finding that is similar to those of previous studies conducted in Caucasian populations (ASTRUP et al. 1999; KLANNEMARK et al. 1998; ROSMOND et al. 2002) . The average BMI was 26.4, 26.8, and 25.7 for the AlaAla, AlaVal, and ValVal type (Table 1) , respectively, which was very similar to the report by ROSMOND et al., which reported BMI of 26.5, 26.1, and 25.7 for the AlaAla, AlaVal and ValVal types, respectively, in the Swedish population (ROSMOND et al. 2002) . In a study among Italian subjects, the frequency of the Val allele was lower in obese subjects compared with control subjects (MAESTRINI et al. 2003) . Until now, only a few reports have been found about the effects of the Ala55Val polymorphism on CTmeasured fat tissue area in East Asian populations. In this paper, we elucidated the association between the Ala55Val polymorphism and cross-sectional areas of abdominal subcutaneous fat, visceral fat, and thigh subcutaneous fat ( Table 2) . Results of this study showed that the ValVal type of the UCP-2 gene was significantly associated with smaller abdominal subcutaneous fat and abdominal total fat areas (p00.044 and p 00.043, respectively). In this study, the effects of calorie restriction on the body compositions of the subjects were also compared according to the Ala55Val polymorphism. There was no difference in the calorie restriction-induced changes of protein, mineral, or water content related to the Ala55Val polymorphism. However, calorie restrictioninduced reduction of body fat was significantly lower in the ValVal type compared with the AlaAla and AlaVal types (p00.016) ( Table 3) . ASTRUP et al. reported that energy expenditure during 24 h was lower in the ValVal type, by 311 and 299 kj day (1 , compared with the AlaAla and AlaVal type, respectively; fat oxidation was also found to be significantly decreased in the ValVal type (ASTRUP et al. 1999) . BUEMANN et al. (2001) also reported that, when the same work was performed, energy expenditure was lower in ValVal type subjects than in subjects of other types. These previous studies showed that the ValVal type was associated with lower energy expenditure, and may provide some explanation for the results of our study. Table 4 shows that the Ala55Val polymorphism was not associated with biochemical parameters in this study, even though it had significant effects on body fat. It is well known that visceral fat is related to aberrant metabolic profiles (BJÖ RNTORP 1991), but the relationship between subcutaneous fat and metabolic syndrome has not yet been identified. MATSUZAWA et al. (1995) suggested that the visceral fat to subcutaneous fat ratio (V/S ratio) is a better indicator of metabolic syndrome than most other parameters. In this study, the Ala55Val polymorphism was not found to be significantly associated with the p-values were obtained by general linear model analysis adjusted for age and initial protein mass. 8) p-values were obtained by general linear model analysis adjusted for age and initial mineral mass. 9) p-values were obtained by general linear model analysis adjusted for age and initial water mass. visceral fat area or V/S ratio, thus providing some explanation for the similar metabolic profiles among the Ala55Val genotypes. In summary, the Ala55Val polymorphism of the UCP-2 gene was associated with abdominal subcutaneous fat area and calorie restriction-induced body fat reduction in Korean female subjects.
